WHO expert panel strongly advises against use of hydroxychloroquine to prevent covid-19
Drug is no longer a research priority; resources should focus on other more promising drugs to prevent covid-19
2021-03-02
(Press-News.org) The anti-inflammatory drug hydroxychloroquine should not be used to prevent infection in people who do not have covid-19, say a WHO Guideline Development Group (GDG) panel of international experts in The BMJ today.
Their strong recommendation is based on high certainty evidence from six randomised controlled trials involving over 6,000 participants with and without known exposure to a person with covid-19 infection.
High certainty evidence showed that hydroxychloroquine had no meaningful effect on death and admission to hospital, while moderate certainty evidence showed that hydroxychloroquine had no meaningful effect on laboratory confirmed covid-19 infection and it probably increases the risk of adverse effects.
As such, the panel considers that this drug is no longer a research priority and that resources should be used to evaluate other more promising drugs to prevent covid-19.
This guideline applies to all individuals who do not have covid-19, regardless of their exposure to a person with covid-19 infection.
The panel judged that almost all people would not consider this drug worthwhile, and also decided that factors such as resources, feasibility, acceptability, and equity for countries and healthcare systems were unlikely to alter the recommendation.
Today's recommendation is the first version of a living guideline for drugs to prevent covid-19, developed by the World Health Organization with the methodological support of MAGIC Evidence Ecosystem Foundation. It's aim is to provide trustworthy guidance on the management of covid-19 and help doctors make better decisions with their patients.
Living guidelines are useful in fast moving research areas like covid-19 because they allow researchers to update previously vetted and peer reviewed evidence summaries.
New recommendations for other preventive drugs for covid-19 will be added to this guideline as more evidence becomes available.
INFORMATION:
Peer reviewed? Yes
Evidence type: Clinical practice guideline
Subjects: Drugs to prevent covid-19
ELSE PRESS RELEASES FROM THIS DATE:
2021-03-02
LOS ANGELES -- COVID-19 has taken a huge medical, emotional and economic toll on Americans. Now, new Keck Medicine of USC research shows that the pandemic may also have harmful indirect consequences.
Alcohol and tobacco sales nationwide rose in the early months of COVID-19, according to a study appearing in the Annals of Internal Medicine today. From April - June 2020, researchers found that sales of these substances increased 34% and 13% respectively when compared to the same months in 2019.
"These are significant jumps, and show that the stress, boredom and loneliness caused by the pandemic may have led to increased alcohol and tobacco ...
2021-03-02
GALVESTON, Texas -A team from The University of Texas Medical Branch at Galveston (UTMB) focused on drug addiction research have pioneered a new way to study frustration as a factor in substance use disorders. The study was published in the medical journal Psychopharmacology.
Traditional addiction research has focused on three aspects of substance use disorders: craving, impulsivity, or habit. Scientists hypothesized that a fourth factor, frustration, could also lead to escalation of drug use and addiction.
The Psychopharmacology paper noted that research into the role of frustration and substance use disorders ...
2021-03-01
Philadelphia, Pa. -- More than one out of every 10 seniors (10.5%) enrolled in a Medicare Advantage plan, also known as a Medicare managed care option, and living in a rural area, switched to traditional Medicare during 2010-2016. The switch was driven primarily due to low satisfaction with care access, according to a study published this week in Health Affairs from researchers at Drexel University's Dornsife School of Public Health. By contrast, only 1.7% of rural traditional Medicare enrollees made the switch to Medicare Advantage during this period.
The findings, among the first to look ...
2021-03-01
Early exposure to tough conditions--particularly warmer waters and nightly swings of low oxygen--could leave lasting scars on oysters' ability to grow meaty tissue. A team of biologists at the Smithsonian Environmental Research Center (SERC) reported the discovery in a new study, published online Feb. 26 in the journal Ecological Applications.
Eastern oysters in Chesapeake Bay live mostly in shallow tributaries. It's a rough environment for shellfish that can't move. During hotter months, oxygen levels can swing drastically, from perfectly healthy ...
2021-03-01
Three studies - one each in Science, Science Translational Medicine, and Science Immunology - reveal the promise of newly engineered bispecific antibodies, including by demonstrating their power against previously inaccessible tumor cell targets for the first time, in two cases. These bispecific antibodies, which simultaneously bind to tumor antigens and T cells, cleared cancer cells without damaging healthy cells in mouse tumor models and/or cell culture experiments, across the three studies. The results highlight the therapeutic potential of this antibody type, which - unlike engineered immune cell therapies like CAR T - does not have to ...
2021-03-01
In the middle of the Indian Ocean lies some of the last coral reef wilderness on Earth. The Chagos Archipelago, a collection of atolls, including Earth's largest - the Great Chagos Bank- is home to reefs that have been largely undisturbed by humans for the last 50 years. Some estimates indicate the Chagos Archipelago may contain more than half of the healthy coral reefs remaining in the entire Indian Ocean. These reefs are protected both by their remote location, and in one of the world's largest no-take marine reserves--the British Indian Ocean Territory (BIOT) marine protected area.
In 2015, scientists at the Khaled ...
2021-03-01
Youth enrollment in Medicaid managed care across all states increased from 65 percent in 2000 to 94 percent in 2017.
Across the country, receipt of preventive care for youth in Medicaid managed care increased from 49 percent in 2000 to 59 percent in 2017, falling short of the 80 percent annual goal set by the Centers for Medicare and Medicaid Services (CMS).
Receipt of preventive care for youth in Medicaid managed care showed a significant increase in 17 states, a significant drop in six states, and no change in 28 states. Tennessee had the largest increase in preventive care associated with Medicaid managed care, while North Carolina showed the largest decrease.
Nationally, the number of children under age 21 enrolled in Medicaid grew from ...
2021-03-01
A school-based cavity prevention program involving nearly 7,000 elementary school students reduced cavities by more than 50 percent, according to a study led by researchers at NYU College of Dentistry. The findings are END ...
2021-03-01
White blood cells or lymphocytes are the soldiers of our immune system that patrol the body via the lymphatic system. While their primary role is to protect the body by scavenging invaders, they can sometimes go rogue and become the enemy. Lymphoma, a type of blood cancer, results from the uncontrolled proliferation of lymphocytes. They are classified as Hodgkins and Non-Hodgkins lymphomas on the basis of the cell of origin and clinical characteristics. Of them, diffuse large B-cell lymphoma (DLBCL) is the most common Non-Hodgkins lymphoma and is highly aggressive and fast-growing.
A combination of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is the standard treatment regimen for ...
2021-03-01
In a new commentary for the journal Science, an associate vice president for research at The University of Texas at Arlington argues that emerging protein-based immunotherapies could lead to highly effective "off-the-shelf" cancer treatments for more patients.
Jon Weidanz, who also is a professor in the College of Nursing and Health Innovation at UTA, is the author of a perspective regarding the development of cancer immunotherapies.
His article, "Targeting cancer with bispecific antibodies," will appear in the March 5 edition of Science. It evaluates the findings of three studies by researchers at Johns Hopkins University and proposes that an emerging ...
LAST 30 PRESS RELEASES:
[Press-News.org] WHO expert panel strongly advises against use of hydroxychloroquine to prevent covid-19
Drug is no longer a research priority; resources should focus on other more promising drugs to prevent covid-19
